Cargando…

Significance of the BRAF mRNA Expression Level in Papillary Thyroid Carcinoma: An Analysis of The Cancer Genome Atlas Data

BACKGROUND: BRAF(V600E) is the most common mutation in papillary thyroid carcinoma (PTC), and it is associated with high-risk prognostic factors. However, the significance of the BRAF mRNA level in PTC remains unknown. We evaluated the significance of BRAF mRNA expression level by analyzing PTC data...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chai, Young Jun, Yi, Jin Wook, Jee, Hyeon-Gun, Kim, Young A, Kim, Ju Han, Xing, Mingzhao, Lee, Kyu Eun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943731/ https://www.ncbi.nlm.nih.gov/pubmed/27410688 http://dx.doi.org/10.1371/journal.pone.0159235

Ejemplares similares

Induction of the BRAF(V600E) Mutation in Thyroid Cells Leads to Frequent Hypermethylation
por: Yi, Jin Wook, et al.
Publicado: (2022)

VDR mRNA overexpression is associated with worse prognostic factors in papillary thyroid carcinoma
por: Choi, June Young, et al.
Publicado: (2017)

The Significance of TROP2 Expression in Predicting BRAF Mutations in Papillary Thyroid Carcinoma
por: Kong, Joon Seog, et al.
Publicado: (2018)

BRAF(V600E) Mutation Enhances Estrogen-Induced Metastatic Potential of Thyroid Cancer by Regulating the Expression of Estrogen Receptors
por: Kim, Minjun, et al.
Publicado: (2022)

Predicting Extrathyroidal Extension in Patients With Papillary Thyroid Microcarcinoma According to a BRAF Mutation
por: Lee, Doh Young, et al.
Publicado: (2017)

Different Molecular Phenotypes of Progression in BRAF- and RAS-Like Papillary Thyroid Carcinoma
por: Lim, Jinsun, et al.
Publicado: (2023)

Tumorigenesis of Papillary Thyroid Cancer Is Not BRAF-Dependent in Patients with Acromegaly
por: Kim, Hee Kyung, et al.
Publicado: (2014)

BRAF in Papillary Thyroid Carcinoma
por: Lanzilotta, Salvatore Giovanni, et al.
Publicado: (2007)

Response to Letter to the Editor From Boucai et al: “BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer”
por: Xing, Mingzhao
Publicado: (2022)

Comprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid Cancers
por: Yoo, Seong-Keun, et al.
Publicado: (2016)

Clinical characteristics of papillary thyroid carcinoma arising from the pyramidal lobe
por: Yoon, Sang Gab, et al.
Publicado: (2017)

BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients
por: Jin, Langping, et al.
Publicado: (2016)

Epigenetically upregulated WIPF1 plays a major role in BRAF V600E-promoted papillary thyroid cancer aggressiveness
por: Zhang, Tao, et al.
Publicado: (2016)

Ultrasound and clinicopathological features of papillary thyroid carcinomas with BRAF and TERT promoter mutations
por: Hahn, Soo Yeon, et al.
Publicado: (2017)

BRAF Testing in Multifocal Papillary Thyroid Carcinoma
por: Kimbrell, Hillary Z., et al.
Publicado: (2015)

Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis
por: Kim, Woon Won, et al.
Publicado: (2018)

Addition of funding statement: Clinical characteristics of papillary thyroid carcinoma arising from the pyramidal lobe
por: Yoon, Sang Gab, et al.
Publicado: (2017)

Can Ultrasound Be as a Surrogate Marker for Diagnosing a Papillary Thyroid Cancer? Comparison with BRAF Mutation Analysis
por: Seo, Jae Young, et al.
Publicado: (2014)

Prevalence of BRAF(V600E) Mutation in Follicular Variant of Papillary Thyroid Carcinoma and Non-Invasive Follicular Tumor with Papillary-Like Nuclear Features (NIFTP) in a BRAF(V600E) Prevalent Area
por: Kim, Hyereen, et al.
Publicado: (2018)

Impact of Extranodal Extension on Risk Stratification in Papillary Thyroid Carcinoma
por: Kim, Hye In, et al.
Publicado: (2019)

Downregulation of SMOC2 expression in papillary thyroid carcinoma and its prognostic significance
por: Kim, Hye Sung, et al.
Publicado: (2020)

Significance of distance between tumor and thyroid capsule as an indicator for central lymph node metastasis in clinically node negative papillary thyroid carcinoma patients
por: Seong, Chan Yong, et al.
Publicado: (2018)

The Expression of Tumor-Associated Macrophages in Papillary Thyroid Carcinoma
por: Kim, Seunghwan, et al.
Publicado: (2013)

Association analysis and the clinical significance of BRAF gene mutations and ultrasound features in papillary thyroid carcinoma
por: Liu, Ying, et al.
Publicado: (2019)

Prognostic Significance of COX-2 Overexpression in BRAF-Mutated Middle Eastern Papillary Thyroid Carcinoma
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2020)

A Case of Multifocal Papillary Thyroid Carcinoma Consisting of One Encapsulated Follicular Variant with BRAF K601E Mutation and Three Conventional Types with BRAF V600E Mutation
por: Kim, Wook Youn, et al.
Publicado: (2013)

Cross-Regulation between Oncogenic BRAF(V600E) Kinase and the MST1 Pathway in Papillary Thyroid Carcinoma
por: Lee, Seong Jin, et al.
Publicado: (2011)

Association between Iodine Intake, Thyroid Function, and Papillary Thyroid Cancer: A Case-Control Study
por: Kim, Kyungsik, et al.
Publicado: (2021)

The Utility of BRAF Testing in the Management of Papillary Thyroid Cancer
por: Melck, Adrienne L., et al.
Publicado: (2010)

TERT Promoter and BRAF V600E Mutations in Papillary Thyroid Cancer: A Single-Institution Experience in Korea
por: Kim, Min Jhi, et al.
Publicado: (2022)

Transoral endoscopic surgery for papillary thyroid carcinoma: initial experiences of a single surgeon in South Korea
por: Yi, Jin Wook, et al.
Publicado: (2018)

Clinical implication of the BRAF(V600E) mutation in papillary thyroid carcinoma
por: Kim, Yong-Seok, et al.
Publicado: (2013)

BRAF mutation may predict higher necessity of postoperative radioactive iodine ablation in papillary thyroid cancer
por: Han, Sang-Ah, et al.
Publicado: (2014)

Associations of the BRAF(V600E) Mutation with Sonographic Features and Clinicopathologic Characteristics in a Large Population with Conventional Papillary Thyroid Carcinoma
por: Park, Ah Young, et al.
Publicado: (2014)

Significance of the Extracapsular Spread of Metastatic Lymph Nodes in Papillary Thyroid Carcinoma
por: Park, Chang Ho, et al.
Publicado: (2015)

Clinicopathological Significance of Minimal Extrathyroid Extension in Solitary Papillary Thyroid Carcinomas
por: Woo, Chang Gok, et al.
Publicado: (2015)

Clinical Significance of PEAK1 Expression and BRAF V600E Mutation in Papillary Thyroid Cancer
por: Li, P., et al.
Publicado: (2022)

Shifted termination assay (STA) fragment analysis to detect BRAF V600 mutations in papillary thyroid carcinomas
por: Kang, So Young, et al.
Publicado: (2013)

Active and Passive Smoking, BRAF(V600E) Mutation Status, and the Risk of Papillary Thyroid Cancer: A Large-Scale Case-Control and Case-Only Study
por: Kim, Kyoung-Nam, et al.
Publicado: (2019)

Prognostic Significance of BRAF V600E Mutation and CPSF2 Protein Expression in Papillary Thyroid Cancer
por: Ivković, Irena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rrnaarlkf0586o3tgmcmce083q